Sabra Healthcare REIT (NASDAQ:SBRA) Reaches New 1-Year High – Still a Buy?

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA)’s stock price hit a new 52-week high during trading on Wednesday . The company traded as high as $21.28 and last traded at $21.1120, with a volume of 223916 shares changing hands. The stock had previously closed at $21.01.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on SBRA. Cantor Fitzgerald increased their price target on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a report on Monday, May 11th. Wall Street Zen raised shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a report on Monday. Citigroup increased their price target on shares of Sabra Healthcare REIT from $21.00 to $24.00 and gave the company a “buy” rating in a report on Wednesday, February 18th. Scotiabank increased their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “sector perform” rating in a research report on Monday, March 2nd. Finally, Truist Financial increased their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “hold” rating in a research report on Friday, March 13th. Five investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $22.20.

Sabra Healthcare REIT Trading Up 0.1%

The firm has a market capitalization of $5.30 billion, a PE ratio of 33.44, a price-to-earnings-growth ratio of 1.67 and a beta of 0.67. The stock’s 50-day moving average price is $20.31 and its 200 day moving average price is $19.58. The company has a debt-to-equity ratio of 0.96, a current ratio of 4.72 and a quick ratio of 4.72.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, hitting analysts’ consensus estimates of $0.16. The business had revenue of $221.75 million for the quarter, compared to analyst estimates of $209.20 million. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The company’s quarterly revenue was up 20.9% compared to the same quarter last year. During the same period last year, the company posted $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, sell-side analysts expect that Sabra Healthcare REIT, Inc. will post 1.5 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 29th. Stockholders of record on Friday, May 15th will be given a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, May 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.7%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 190.48%.

Hedge Funds Weigh In On Sabra Healthcare REIT

A number of institutional investors have recently modified their holdings of SBRA. Cornerstone Wealth Management LLC increased its holdings in Sabra Healthcare REIT by 256.6% during the third quarter. Cornerstone Wealth Management LLC now owns 39,781 shares of the real estate investment trust’s stock valued at $742,000 after buying an additional 28,625 shares during the period. AlphaQuest LLC increased its holdings in Sabra Healthcare REIT by 309.2% during the third quarter. AlphaQuest LLC now owns 144,839 shares of the real estate investment trust’s stock valued at $2,700,000 after buying an additional 109,444 shares during the period. Bank of Montreal Can increased its holdings in Sabra Healthcare REIT by 8.2% during the third quarter. Bank of Montreal Can now owns 2,787,655 shares of the real estate investment trust’s stock valued at $51,962,000 after buying an additional 211,686 shares during the period. Allianz Asset Management GmbH increased its holdings in Sabra Healthcare REIT by 9.9% during the third quarter. Allianz Asset Management GmbH now owns 902,998 shares of the real estate investment trust’s stock valued at $16,832,000 after buying an additional 81,293 shares during the period. Finally, Greenland Capital Management LP purchased a new position in Sabra Healthcare REIT during the third quarter valued at approximately $4,194,000. 99.40% of the stock is owned by hedge funds and other institutional investors.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.